Thermo Fisher gets CE Mark for COVID-19 test

LabPulse.com staff writers
Mar 26, 2020
2019 11 08 01 30 1068 Thermo Fisher Amp 2019 V3 400

Thermo Fisher Scientific has received the CE Mark in Europe to market and sell its rapid test for SARS-CoV-2, which causes the respiratory disease COVID-19.

The test utilizes Thermo Fisher's Applied Biosystems TaqPath assay and real-time polymerase chain reaction (PCR) technology to detect nucleic acid from SARS-CoV-2. Labs can use the test to process the results within four hours, including time for sample preparation and instrument analysis.

Thermo Fisher's test has also received approvals from the U.S., Canada, Singapore, India, Australia, and New Zealand. Furthermore, the company created an online resource for information related to the COVID-19 pandemic.

Latest in PCR
Money Bag Grant Award Social
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
March 4, 2024
Influenza Virus Social
Thermo Fisher launches new instrument, kit for respiratory testing
December 11, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Test Tubes Social
NIH researchers develop PCR assay for easier diagnosis of river blindness
October 9, 2023
Related Stories
3d Closeup Coronavirus
COVID-19
Thermo Fisher Scientific unveils digital PCR wastewater surveillance kit for SARS-CoV-2
Lab Scientists Petri Resized
Clinical Trial
Thermo Fisher announces decentralized clinical trials network
2020 05 07 22 15 9104 Thermo Fisher Scientific 400
Research and Development
Thermo Fisher expands COVID-19 therapies, vaccines
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in PCR
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Money Bag Grant Award Social
Thermo Fisher launches new instrument, kit for respiratory testing
By LabPulse.com staff writers
Thermo Fisher Scientific has launched a nucleic acid purification instrument and kit for automated viral and bacterial respiratory testing.
December 11, 2023
Influenza Virus Social
Researchers develop technique for onsite detection of SARS-CoV-2
By LabPulse.com staff writers
Researchers have developed a portable laboratory device for rapid onsite detection of SARS-CoV-2 RNA which holds promise for scenarios in which there is no or limited access to testing laboratories.
October 10, 2023
Coronavirus Covid Blue Social
NIH researchers develop PCR assay for easier diagnosis of river blindness
By LabPulse.com staff writers
U.S. National Institutes of Health (NIH) researchers have developed a new PCR assay to detect Onchocerca volvulus, the parasite that causes onchocerciasis, or river blindness, and are working to adapt it for easier field diagnosis of the disease.
October 9, 2023
Test Tubes Social
Nonprofit health system adopts Immunexpress test for detecting sepsis
By Nick Paul Taylor
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
Bacteria Blood Sepsis Social
ChromaCode starts early-access launch of lung cancer variant test
By Nick Paul Taylor
The test is designed to address diagnostic problems that prevent patients from undergoing timely cancer biomarker testing and receiving targeted therapies.
August 15, 2023
Lung Cancer Hotspot Social
Studies show Pathnostics UTI test required fewer resources, reduced costs compared to standard testing
By LabPulse.com staff writers
In the study, the average one-year costs related to UTIs were $501.85 lower for patients receiving treatment based on the Guidance test than for those receiving treatment based on the traditional culture test.
June 20, 2023
Bladder Urinary 3 D Social
Roche receives WHO prequalification for HPV screening tool
By LabPulse.com staff writers
Prequalification helps expand access to the screening tool in countries that rely on the WHO's list of prequalified suppliers in making purchasing and implementation decisions.
June 13, 2023
Lab Woman Dna Social
Eurobio Scientific obtains IVDR CE markings for PCR tests
By LabPulse.com staff writers
The CE markings enable the firm to market three of its PCR tests as class C in vitro diagnostic medical devices for the detection of infectious diseases.
May 24, 2023
Business Regulation Graphic Social Resized
A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab
By LabPulse.com staff writers
The system, Prime MDx, is an all-in-one, sample-to-result platform designed to allows users to process a variety of sample types through real-time polymerase chain reaction (PCR), the Florence, Italy-based firm said.
May 23, 2023
Artificial Intelligence Ai Social
BioMĂ©rieux receives FDA CLIA waiver for multiplex PCR respiratory panel
By LabPulse.com staff writers
In about 15 minutes, the panel detects five of the most common viral causes of upper respiratory tract infections: SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus (RSV), and rhinovirus.
May 11, 2023
Patient Doctor Women Social
Bio-Rad Laboratories Q1 net sales drop 3%; firm lowers full-year guidance
By LabPulse.com staff writers
Bio-Rad shares were down on Friday, a day after the firm updated its financial outlook for full-year 2023; it anticipates non-GAAP currency-neutral revenue growth of approximately 4.5% compared to its previous estimate of 6% to 7%.
May 5, 2023
Business Financial Results Social
Page 1 of 23
Next Page